MedTrace Logo

Efficacy of NIV Masks in COPD

NCT04947852 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2022-03-18

No results posted yet for this study

Summary

A randomized controlled pilot study to compare the efficacy and tolerability of a two different NIV masks on carbon dioxide in participants with stable chronic obstructive pulmonary disease (COPD) with chronic type II respiratory failure.

Conditions

Interventions

DEVICE

Investigation Mask

Oronasal bilevel continuous positive airway pressure mask fitted by the investigational staff

DEVICE

Comparator Mask

Oronasal bilevel continuous positive airway pressure mask fitted by the investigational staff

Sponsors & Collaborators

  • Fisher and Paykel Healthcare

    lead INDUSTRY

Principal Investigators

  • Alex Semprini · Medical Research Institute of New Zealand

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-07-28
Primary Completion
2022-03-17
Completion
2022-03-17

Countries

  • New Zealand

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04947852 on ClinicalTrials.gov